Lisa Martin
Adolescent Medicine · Greencastle, INNPI 1821046202
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations.
Across 63 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$134
- Lilly USA, LLC$125
- AstraZeneca$120
- Novo Nordisk$103
- GSK$73
- Ironshore Pharmaceuticals Inc.$65
- plus $543 from 21 others
What the payments were for
- Food & beverage$1,161100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $134 |
| Lilly USA, LLC | 7 | $125 |
| AstraZeneca | 5 | $120 |
| Novo Nordisk | 5 | $103 |
| GSK | 5 | $73 |
| Ironshore Pharmaceuticals Inc. | 4 | $65 |
| Ultragenyx Pharmaceutical Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Amgen | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Corium, LLC | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $30 |
| Boehringer Ingelheim | 2 | $30 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Tris Pharma Inc | 2 | $26 |
| KCI USA, Inc. | 1 | $25 |
| Abbott | 1 | $21 |
| Biogen | 1 | $20 |
| Merck | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Novartis | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
$1,161 in reported general payments places this provider in the 65th percentile of 21 adolescent medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 32 | $48,610 |
| EliquisApixaban | 44 | $39,815 |
| JardianceEmpagliflozin | 28 | $36,991 |
| FarxigaDapagliflozin Propanediol | 22 | $29,073 |
| OzempicSemaglutide | 17 | $16,182 |
| TrulicityDulaglutide | 14 | $13,487 |
| MyrbetriqMirabegron | 13 | $11,131 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $5,097 |
| Humalog Kwikpen U-100Insulin Lispro | 22 | $5,081 |
| Celecoxib | 60 | $2,618 |
| OsphenaOspemifene | 11 | $2,502 |
| Omeprazole | 104 | $1,948 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 96 | $1,880 |
| Atorvastatin Calcium | 217 | $1,834 |
| Rosuvastatin Calcium | 155 | $1,798 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $125 | $62,09846 claims |
| Boehringer IngelheimJardiance | $30 | $36,99128 claims |
| AstraZenecaFarxiga | $120 | $29,07322 claims |
| Novo NordiskOzempic, Novolog | $103 | $17,03229 claims |
| AbbVieSynthroid | $134 | $64713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 21 adolescent medicine providers in Indiana.
Other adolescent medicine in Greencastle
- Mary OttIndianapolis$4K
- Chrissa CollingsIndpls$3K
- Lanette Brown JonesIndianapolis$3K
- Carolyn RobinsonCarmel$2K
- Ryan MughmawSeymour$2K
- Anne StumpIndianapolis$2K
- Brenda ThompsonGary$1K
- Krista SantosIndianapolis$835
- Pradeep GuptaMuncie$592
- Mualla AkisikNoblesville$364
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.